Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.

Learn about the origins of the medical affairs function, how far it’s come and where it may be heading in the future as key proprietor of patient centricity.

Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Global Medical Affairs, Ipsen shares her thoughts on pharma’s mission to help improve patient lives, challenges that hinder patient centricity and seeking knowledge across industries.

The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.

Establishing a brand-new multinational legal system was never going to be easy, but why has it taken so long and what is the outlook?

In an era when UX is becoming fundamental to businesses globally, the role of design teams in pharma companies is taking on a whole new meaning.

Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article explores this phenomenon in healthcare and the key lessons pharma can take when creating their own innovative products.